DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Drospirenone, Ethinyl Estradiol And Levomefolate Calcium patents expire, and what generic alternatives are available?
Drospirenone, Ethinyl Estradiol And Levomefolate Calcium is a drug marketed by Lupin Ltd and Watson Labs Inc and is included in three NDAs.
The generic ingredient in DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM is drospirenone; ethinyl estradiol; levomefolate calcium. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM?
- What are the global sales for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM?
- What is Average Wholesale Price for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM?
Summary for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM at DailyMed |
Recent Clinical Trials for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bayer | Phase 3 |
See all DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM clinical trials
US Patents and Regulatory Information for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 205947-001 | Jun 13, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Inc | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 203593-001 | Oct 11, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Inc | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 203594-001 | Oct 11, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
